IO Biotech, Inc.
IOBT
$1.72
$0.010.59%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.16% | -11.25% | -10.93% | -12.96% | -18.95% |
| Total Depreciation and Amortization | 7.93% | 9.08% | 12.30% | 11.54% | 22.39% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 55.81% | 20.09% | 30.89% | -36.33% | 18.51% |
| Change in Net Operating Assets | 493.36% | 405.62% | -62.81% | -109.79% | -123.40% |
| Cash from Operations | -3.26% | 1.82% | -14.79% | -39.12% | -37.18% |
| Capital Expenditure | 52.83% | 67.20% | 86.38% | 74.11% | 75.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 52.83% | 67.20% | 86.38% | 74.11% | 75.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 92.71% | -- | -- | 99.69% | -- |
| Cash from Financing | -84.01% | -- | -- | -100.01% | -- |
| Foreign Exchange rate Adjustments | -100.57% | -45.42% | -196.01% | -92.07% | 36.01% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -676.81% | -667.15% | -13,891.38% | -695.24% | 84.43% |